Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the second quarter of 2023.

In this edition, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.

We wrap up the Roundup with a summary of class action settlements finalized in the second quarter.

Read the Roundup

 
Meet the Authors
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.